Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Cancer statistics, 2023
2023 Standout
Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome
2007
HER-2/neu Analysis in Archival Tissue Samples of Human Breast Cancer: Comparison of Immunohistochemistry and Fluorescence In Situ Hybridization
2001
Delineation of HER2 Gene Status in Breast Carcinoma by Silver in Situ Hybridization is Reproducible among Laboratories and Pathologists
2008
Characterization of Epithelial Progenitors in Normal Human Palatine Tonsils and Their HPV16 E6/E7-Induced Perturbation
2015
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Triple Negative Breast Carcinoma and the Basal Phenotype: From Expression Profiling to Clinical Practice
2007
Heparan sulfate 3-O-sulfation: A rare modification in search of a function
2013
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas
2008
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma
2001
Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
2016
Triple-negative breast cancer: therapeutic options
2007
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis
2004
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Chromogenic in situ hybridization for Her‐2/neu‐oncogene in breast cancer: comparison of a new dual‐colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
2009
Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings
2009
Triple-Negative Breast Cancer
2010 Standout
Determining True HER2 Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy
2011
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Cancer statistics, 2024
2024 Standout
Prognostic Significance of the 2004 WHO/ISUP Classification for Prediction of Recurrence, Progression, and Cancer-Specific Mortality of Non–Muscle-Invasive Urothelial Tumors of the Urinary Bladder
2010
Retroperitoneal Leiomyomas
2001
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification
2011 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants
2006
A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making
2013
Renal Cell Carcinoma in Tuberous Sclerosis Complex
2014
Histologic Grading of Noninvasive Papillary Urothelial Tumors : Validation of the 1998 WHO/ISUP System by Immunophenotyping and Follow-up
2004
Urothelial Carcinoma with Divergent Histologic Differentiation (Mixed Histologic Features) Predicts the Presence of Locally Advanced Bladder Cancer When Detected at Transurethral Resection
2007
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Head and neck cancer
2008 Standout
Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance
2003
A Malnutrition-Inflammation Score is correlated with morbidity and mortality in maintenance hemodialysis patients
2001 Standout
The human keratins: biology and pathology
2008 Standout
Renal angiomyolipomata
2004
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology
2012
Male Breast Carcinoma: Correlation of ER, PR, Ki-67, Her2-Neu, and p53 with Treatment and Survival, a Study of 65 Cases
2002
Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression
2002
Vintage, nutritional status, and survival in hemodialysis patients
2000
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
Urothelial (Transitional Cell) Papilloma of the Urinary Bladder: A Clinicopathologic Study of 26 Cases
2003
Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab
2005
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Comparison of HER‐2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma
2005
Biological roles of glycans
2016 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Colorectal cancer
2019 Standout
Impact of Clinical and Non-Clinical Factors on the Choice of HER2 Test for Breast Cancer
2010
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Ductal Carcinoma In Situ, Complexities and Challenges
2004
Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications
2006
Bladder cancer
2016 Standout
Male breast cancer
2006 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Expression of HER‐2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in‐situ hybridization and immunohistochemistry
2003
Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study
2009
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma
2009
Tuberous sclerosis
2008 Standout
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
2009
Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients
2006
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
2010
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Clear Cell Renal Cell Carcinoma
2005
What Is the Significance of Variant Histology in Urothelial Carcinoma?
2019
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer
2013 StandoutNobel
The molecular landscape of head and neck cancer
2018 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Status of HER-2 in male and female breast carcinoma
2001
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Handling and Pathology Reporting of Specimens with Carcinoma of the Urinary Bladder, Ureter, and Renal Pelvis
2003
ROS and the DNA damage response in cancer
2018 Standout
The evolving classification of soft tissue tumours: an update based on the new WHO classification
2005 Standout
Challenges in the treatment of bladder cancer
2006
Renal cell carcinoma
2017 Standout
Diagnostic Use of Antibody to Smoothelin in the Recognition of Muscularis Propria in Transurethral Resection of Urinary Bladder Tumor (TURBT) Specimens
2010
Histologic grading of urothelial carcinoma: a reappraisal
2012
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
The pathology of bladder cancer
2006
Non-Invasive Urothelial Neoplasms: According to the Most Recent WHO Classification
2004
Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and genetics
2004
Chronic oxidative stress promotes H2 AX protein degradation and enhances chemosensitivity in breast cancer patients
2016
Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes
2004
Digital terrain modelling: A review of hydrological, geomorphological, and biological applications
1991 Standout
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon
2016
Tumour stem cells and drug resistance
2005 Standout
Breast Cancer Statistics, 2022
2022 Standout
The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer
2006
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
2019
An anisotropic hourly diffuse radiation model for sloping surfaces: Description, performance validation, site dependency evaluation
1986
Bladder Cancer
2020 Standout
The Tuberous Sclerosis Complex and its Highly Variable Manifestations
2003
Quality of diagnostic staging in patients with bladder cancer: A process‐outcomes link
2014
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Evaluation of models for predicting insolation on slopes within the Colorado alpine tundra
1986
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Chromogenic In Situ Hybridization to Detect HER-2/neu Gene Amplification in Histological and ThinPrep®-Processed Breast Cancer Fine-Needle Aspirates: A Sensitive and Practical Method in the Trastuzumab Era
2006
Modeling daylight availability and irradiance components from direct and global irradiance
1990 Standout
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
2002
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps
2013
Second-Line Systemic Therapy for Metastatic Urothelial Carcinoma of the Bladder
2013
Works of Rafael E. Jiménez being referenced
Global Methylation Profiling for Risk Prediction of Prostate Cancer
2012
Surveillance after prostate focal therapy
2018
Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ Hybridization
2000
Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.
2001
pT1 Urothelial Carcinoma of the Bladder: Criteria for Diagnosis, Pitfalls, and Clinical Implications
2000
Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features
2010
Development of Gastrointestinal β2-Microglobulin Amyloidosis Correlates With Time on Dialysis
1998
Concurrent Angiomyolipoma and Renal Cell Neoplasia: A Study of 36 Cases
2001
Grading the Invasive Component of Urothelial Carcinoma of the Bladder and Its Relationship With Progression-Free Survival
2000
Immunohistochemical Study of Microphthalmia Transcription Factor and Tyrosinase in Angiomyolipoma of the Kidney, Renal Cell Carcinoma, and Renal and Retroperitoneal Sarcomas
2001
Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ
2000
Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia
2000
Clear Cell Carcinoma of the Urinary Bladder
2002
Multidrug resistance phenotype in high grade soft tissue sarcoma
1999
Clinicopathologic analysis of microscopically invasive breast carcinoma
1998
Centrally Necrotizing Carcinomas of the Breast
2001
Clinicopathologic Significance of Ductal Carcinoma in situ in Breast Core Needle Biopsies With Invasive Cancer
2000
Total and non-isotropic diffuse insolution on tilted surfaces
1980
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century
2019